Drug Database
Back to search

Poland· PL-100178835

Cervarix

A humaner papillomvirus (typen 16, 18) product containing szczepionka przeciw wirusowi brodawczaka ludzkiego [typy 16 i 18] (rekombinowana, z adiuwantem, adsorbowana), registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC J07BM02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCervarixATCJ07BM02REGISTER NO.PL-100178835PACKS LISTED12CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about szczepionka przeciw wirusowi brodawczaka ludzkiego [typy 16 i 18] (rekombinowana, z adiuwantem, adsorbowana)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Humaner papillomvirus (typen 16, 18) is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BM02 (humaner papillomvirus (typen 16, 18)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search humaner papillomvirus (typen 16, 18) products by name

Humaner papillomvirus (typen 16, 18) · ATC J07BM02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka przeciw wirusowi brodawczaka ludzkiego [typy 16 i 18] (rekombinowana, z adiuwantem, adsorbowana)
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Poland (PL)
ATC code
J07BM02
ATC class
Humaner Papillomvirus (Typen 16, 18)
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 12

1 priced
  • gtin
    05909990689941
  • gtin
    05909990689958
  • gtin
    05909990689965
  • gtin
    05909990064748
    1 amp.-strzyk.
    PLN 278.88
  • gtin
    05909990064700
  • gtin
    05909990064724
  • gtin
    05909990064731
  • gtin
    05909990064755
  • gtin
    05909990064762
  • gtin
    05909990064779
  • gtin
    05909990064786
  • gtin
    05909990064793

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BM02

Humaner papillomvirus (typen 16, 18), as other registers publish it.

All humaner papillomvirus (typen 16, 18) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb9b6dea-e8b3-4f69-b029-a21e20f371c1
GET /v1/drugs/fb9b6dea-e8b3-4f69-b029-a21e20f371c1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do wstrzykiwań",
  "source": "urpl",
  "strength": null,
  "packaging": "05909990064700 ¦ Rp ¦ EU/1/07/419/001 ¦ 37192\n1 fiol. 0,5 ml\n05909990064724 ¦ Rp ¦ EU/1/07/419/002 ¦ 37193\n10 fiol. 0,5 ml\n05909990064731 ¦ Rp ¦ EU/1/07/419/003 ¦ 37194\n100 fiol. 0,5 ml\n05909990064748 ¦ Rp ¦ EU/1/07/419/004 ¦ 37195\n1 amp.-strzyk. 0,5 ml ¦ 1 igła \n05909990064755 ¦ Rp ¦ EU/1/07/419/005 ¦ 37196\n1 amp.-strzyk. 0,5 ml ¦ 2 igły \n05909990064762 ¦ Rp ¦ EU/1/07/419/006 ¦ 37197\n10 amp.-strzyk. 0,5 ml ¦ 10 igieł \n05909990064779 ¦ Rp ¦ EU/1/07/419/007 ¦ 37198\n10 amp.-strzyk. 0,5 ml ¦ 20 igieł \n05909990064786 ¦ Rp ¦ EU/1/07/419/008 ¦ 37199\n1 amp.-strzyk. 0,5 ml\n05909990064793 ¦ Rp ¦ EU/1/07/419/009 ¦ 37200\n10 amp.-strzyk. 0,5 ml\n05909990689941 ¦ Rp ¦ EU/1/07/419/010 ¦ 49202\n1 fiol. 1 ml (2 dawki)\n05909990689958 ¦ Rp ¦ EU/1/07/419/011 ¦ 49203\n10 fiol. 1 ml (2 dawki)\n05909990689965 ¦ Rp ¦ EU/1/07/419/012 ¦ 49204\n100 fiol. 1 ml (2 dawki)",
  "substance": null,
  "common_name": "Szczepionka przeciw wirusowi brodawczaka ludzkiego [typy 16 i 18] (rekombinowana, z adiuwantem, adsorbowana)",
  "pl_product_id": "100178835",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about humaner papillomvirus (typen 16, 18).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console